Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus.

[1]  O. Karabay,et al.  Choice of drugs in the treatment of chronic hepatitis B in pregnancy. , 2013, World Journal of Gastroenterology.

[2]  Z. Gao,et al.  Forty‐eight‐week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B‐related cirrhosis , 2013, Journal of viral hepatitis.

[3]  Huaidong Hu,et al.  Efficacy of telbivudine on interruption of hepatitis B virus vertical transmission: a meta-analysis , 2013, Annals of Saudi medicine.

[4]  Yu-zhu Yin,et al.  [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission]. , 2013, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[5]  H. Cai,et al.  Safety of lamivudine treatment for chronic hepatitis B in early pregnancy. , 2012, World journal of gastroenterology.

[6]  C. Yurdaydın,et al.  Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment‐naïve patients with HBV‐related decompensated cirrhosis , 2012, Journal of viral hepatitis.

[7]  G. Borgia,et al.  Hepatitis B in pregnancy. , 2012, World journal of gastroenterology.

[8]  Wei Zhao,et al.  Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  Q. Jiang,et al.  The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[10]  Wei Zhao,et al.  A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. , 2011, Journal of hepatology.

[11]  Xiahong Dai,et al.  Comparison of the efficacy of lamivudine and telbivudine in the treatment of chronic hepatitis B: a systematic review , 2010, Virology Journal.

[12]  H. Zhuang,et al.  [Prevention of hepatitis B virus vertical transmission: current situation and challenges.]. , 2010, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[13]  Hung‐Chih Yang,et al.  Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double‐blind, placebo‐controlled study , 2009, Journal of viral hepatitis.

[14]  M. Jonas.  Hepatitis B and pregnancy: an underestimated issue , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[15]  A. Bisceglie,et al.  Two-year Results from the Globe Trial in Patients with Hepatitis B: Greater Clinical and Antiviral Efficacy for Telbivudine (LdT) vs Lamivudine , 2006 .

[16]  F. Denis,et al.  Virus des hepatites : transmission mere-enfant , 2002 .